Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02216630 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
A Phase 1 study of Chronic Obstructive Pulmonary Disease, sponsored by Kimera Society.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
- 5
- Study locations
NCT02216630 is a Phase 1 study of Chronic Obstructive Pulmonary Disease that has completed, run by Kimera Society. The registered enrollment target is 26 participants, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02216630, a Phase 1 study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by Kimera Society.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
- 5
- Study locations
Study Summary
This will be an open-label, non-randomized multi-center study designed to assess the safety and efficacy of Adipose-derived Stem Cell (ASC) IV implantation. The therapy is composed of cells isolated from a patient's own adipose tissue. Liposuction will be performed to collect the adipose tissue specimen for subsequent processing to isolate the stem cells.
Conditions Studied
Interventions
- DRUG Adipose Derived Stem Cell (ADSC) Therapy
Study Locations (5)
Florida
- Melvin Propis M.D. - Davie
Illinois
- Chicago - Chicago
Nevada
- Las Vegas - Las Vegas
New York
- New York - New York
Texas
- Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02216630
The ClinicalTrials.gov registry entry for NCT02216630 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The listed sponsor is Kimera Society, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Adipose Derived Stem Cell (ADSC) Therapy is the first listed.
NCT02216630 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, Nevada.
Frequently Asked Questions
What is clinical trial NCT02216630 about?
NCT02216630 is a clinical study titled "Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease". This will be an open-label, non-randomized multi-center study designed to assess the safety and efficacy of Adipose-derived Stem Cell (ASC) IV implantation. The therapy is composed of cells isolated from a patient's own adipose tissue. Liposuction will be performed to collect the adipose tissue spec...
What is the current status of trial NCT02216630?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2014-08. Estimated completion is 2017-07.
What conditions does trial NCT02216630 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT02216630?
The interventions under investigation include: Adipose Derived Stem Cell (ADSC) Therapy (DRUG).
Who is sponsoring clinical trial NCT02216630?
This trial is sponsored by Kimera Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02216630 being conducted?
This trial has 5 study locations across Florida, Illinois, Nevada, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of Semaglutide in Advanced Lung Disease
RECRUITING · Phase 1
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
RECRUITING · Phase 1
-
Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
RECRUITING · Phase 1
-
: Vascular Function in Health and Disease
RECRUITING · Phase 1
-
Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)
COMPLETED · Phase 1
-
Mindfulness Based Stress Reduction in COPD
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.